Company intelligence / Profile preview

Cornea Biosciences

California, United Stateslinkedin.com ↗

Ownership: Private
Development stage: Preclinical

Overview

The company has developed a bioengineered/biosynthetic cornea after over a decade of research at the University of Ottawa and Linköping University. The product aims to address global shortages in donor corneas and provide affordable solutions for those suffering from corneal blindness or injury. Clinical/commercial launch depends on securing additional funding; no published clinical trial results yet.

Therapeutic areas: Ophthalmology
Modalities: BiologicDevice (biosynthetic/bioengineered corneal implant)
Industry: Implantable Medical Devices

Partnerships

Collaborations with University of Ottawa and Linköping University for R&D

Beyond the preview

Go deeper on Cornea Biosciences.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cornea Biosciences.

Explore the full profile